Stefanie Frank

Title: Stefanie Frank: Innovator in Genetically Modified Microorganisms

Introduction

Stefanie Frank is a prominent inventor based in Kent, GB. She has made significant contributions to the field of biotechnology, particularly in the development of genetically modified microorganisms. Her innovative work has the potential to impact various industries, including pharmaceuticals and environmental science.

Latest Patents

Stefanie Frank holds a patent for her invention related to genetically modified microorganisms. This invention involves microorganisms that comprise one or more heterologous nucleic acid molecules encoding at least three different proteins. Each protein includes an enzymatic domain and a bacterial microcompartment-targeting signal polypeptide. The enzymatic domains catalyze different substrate-to-product conversions within the same metabolic pathway. Notably, these microorganisms are essentially free of bacterial microcompartments (BMCs). Additionally, her patent covers cell-free systems that include aggregates of at least three different proteins, which also do not comprise bacterial microcompartments. The methods for producing these microorganisms and cell-free systems are also part of her innovative work.

Career Highlights

Stefanie Frank is affiliated with the University of Kent, where she conducts her research and development activities. Her work has garnered attention for its innovative approach to utilizing genetically modified microorganisms for various applications.

Collaborations

Stefanie collaborates with notable colleagues, including Matthew John Lee and Martin James Warren. Their combined expertise enhances the research and development efforts in their respective fields.

Conclusion

Stefanie Frank's contributions to the field of genetically modified microorganisms exemplify her innovative spirit and dedication to advancing biotechnology. Her patent and ongoing research hold promise for future applications that could benefit multiple industries.